Comparison of efficiency of high dose atorvastatin and endothelial progenitor-capture stents and bare metal stents in reduction of neointimal formation in patients with non ST-segment elevation acute coronary syndromes

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 10 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Anti-CD34 monoclonal antibody (Primary) ; Atorvastatin
Indications Acute coronary syndromes; Coronary artery disease; Coronary artery restenosis
Focus Adverse reactions; Therapeutic Use
Acronyms JACK-EPC

Most Recent Events

25 Sep 2010 Six-month results presented at the 22nd Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.
12 Apr 2010 Results presented at the 59th Annual Scientific Session of the American College of Cardiology.
23 Jan 2010 Clinical outcomes presented at Asia PCR/Singapore LIVE, according to an orbusneich media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight